Table 2.
Before randomization | After randomization | T1 | T7 | p* | |||
---|---|---|---|---|---|---|---|
Placebo | mPBMC | p + | |||||
Cognitive function | 19 | 31 | 23 | 0.09 | 8 | 11 | 0.59 |
Motor function | 3 | 0 | 2 | 0.15 | 0 | 0 | – |
Cognitive + motor function | 5 | 14 | 16 | 0.65 | 13 | 14 | 0.83 |
No interval change | 20 | 2 | 6 | 0.13 | 1 | 0 | 0.28 |
mPBMC mobilized peripheral blood mononuclear cell; T1 and T7 refer to a group who received mPBMC at 1 and 7 months of study, respectively
+ p indicates statistical significances of items between placebo and mPBMC groups
*p indicates statistical significances of items between before T1 and T7 groups